Skip to main content
Premium Trial:

Request an Annual Quote

DermTech Posts 48 Percent Jump in Q1 Revenues

NEW YORK — DermTech on Tuesday afternoon reported a 48 percent year-over-year jump in revenues for the first quarter of 2022 but fell just short of Wall Street's expectations.

For the three-month period ended March 31, DermTech's revenues came in at $3.7 million, up from $2.5 million in the year-ago quarter. Analysts had, on average, been expecting Q1 revenues of $3.8 million.

Driving the increase was a roughly 60 percent rise in revenues from the company's noninvasive skin cancer tests to $3.5 million from $2.2 million the year before as billable sample volume grew 53 percent year on year to approximately 14,370.

DermTech's net loss for the first quarter nearly doubled to $30.1 million, or $1.01 per share, from $15.1 million, or $.55 per share, a year earlier, missing Wall Street's consensus loss estimate of $.89 per share.

Contributing to the higher loss was a 174 percent rise in R&D spending to $6.3 million in Q1 2022 from $2.3 million the year before, primarily due to higher employee-related costs and clinical trial expenses. SG&A costs, meantime, more than doubled to $24.0 million from $11.7 million, reflecting higher headcount and marketing expenditures.

At the end of March, DermTech — which went public at the beginning of 2021 — had $145.1 million in cash and cash equivalents, $54.1 million in short-term marketable securities, and $3.0 million in restricted cash.

Looking ahead, La Jolla, California-based DermTech affirmed its earlier full-year 2022 guidance for assay revenue of $22 million to $26 million.

In morning trading on the Nasdaq, DermTech shares were down 4 percent at $9.08.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.